News und Analysen
Allianz Aktie: 0,64% unter 52-Wochen-Hoch
Die Allianz-Aktie ist der bislang stärksten Rally des Dax in diesem Jahr gefolgt, ohne…
Der Beitrag Allianz Aktie: 0,64% unter 52-Wochen-Hoch erschien zuerst auf kapitalmarktexperten.de.
Quelle kapi
Grab Q2 Earnings Call Highlights
Key Points
- Interested in Grab Holdings Limited? Here are five stocks we like better.
- Grab posted record Q2 results: Adjusted EBITDA rose 54% year over year to $168 million, with the margin
Snap Q2 Earnings Call Highlights
Key Points
- Interested in Snap Inc.? Here are five stocks we like better.
- Snap’s second-quarter revenue rose 19% to $1.6 billion, supported by a 9% increase in advertising revenue and an 85%
Ibotta Q2 Earnings Call Highlights
Key Points
- Interested in Ibotta, Inc.? Here are five stocks we like better.
- Ibotta returned to year-over-year growth earlier than expected: Q2 revenue rose 3% to $88.9 million, redemption
Clorox Q4 Earnings Call Highlights
Key Points
- Interested in The Clorox Company? Here are five stocks we like better.
- Fiscal 2027 outlook: Clorox expects organic sales to be flat to slightly higher amid muted category growth and
Vertex Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex reported strong Q2 growth: Revenue rose 12% year over year to $3.3 billion, prompting
Vertex Q2 Earnings Call Highlights
Key Points
- Interested in Vertex, Inc.? Here are five stocks we like better.
- Strong Q2 profitability: Revenue increased 10.5% year over year to $204 million, while adjusted EBITDA rose 33% to $51
Ultra Clean Q2 Earnings Call Highlights
Key Points
- Interested in Ultra Clean Holdings, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose to $644.9 million from $533.7 million in Q1, while net income
Backblaze Q2 Earnings Call Highlights
Key Points
- Interested in Backblaze, Inc.? Here are five stocks we like better.
- Backblaze exceeded Q2 expectations: Revenue rose 18% year over year to $42.7 million, while adjusted EBITDA nearly
Stoke Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Stoke Therapeutics, Inc.? Here are five stocks we like better.
- EMPEROR remains on schedule: Stoke completed enrollment ahead of plan with 162 Dravet syndrome patients
Palantir Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Palantir Technologies Inc.? Here are five stocks we like better.
- Palantir’s Q2 revenue surged 93% year over year to $1.935 billion, led by U.S. revenue growth of 115%
Ichor Q2 Earnings Call Highlights
Key Points
- Interested in Ichor Holdings, Ltd.? Here are five stocks we like better.
- Demand and outlook strengthened: Second-quarter revenue rose 15% sequentially to $294.8 million, while Ichor
Commerzbank Aktie: Showdown am 6. August
Fast zwei Jahre hat sich die Commerzbank gegen UniCredit gewehrt. Jetzt verdichten sich die…
Der Beitrag Commerzbank Aktie: Showdown am 6. August erschien zuerst auf kapitalmarktexperten.de.
Quelle
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity
Key Points
- Interested in Merck & Co., Inc.? Here are five stocks we like better.
- Merck reported positive Phase III results for its once-weekly oral islatravir/lenacapavir HIV regimen, showing
Intel Aktie: Fortinet-Chip auf Intel 4, nicht 18A
Intel notiert bei 78,42 Euro und liegt damit 37 Prozent unter dem 52-Wochen-Hoch vom…
Der Beitrag Intel Aktie: Fortinet-Chip auf Intel 4, nicht 18A erschien zuerst auf kapitalmarktexperten.de.
Quell
Siemens Energy Aktie: Quartalszahlen am 5. August
Der DAX schielt mit knapp 25.900 Punkten schon wieder auf sein Allzeithoch. Siemens Energy…
Der Beitrag Siemens Energy Aktie: Quartalszahlen am 5. August erschien zuerst auf kapitalmarktexperten.de.
Kosmos Energy Q2 Earnings Call Highlights
Key Points
- Interested in Kosmos Energy Ltd.? Here are five stocks we like better.
- Production and costs improved: First-half production rose 18% year over year, while absolute operating costs
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care verzeichnet in Q2 2026 ein operatives Ergebnis ohne Sondereffekte über den Markterwartungen und bestätigt den Ausblick für das Gesamtjahr 2026
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care verzeichnet in Q2 2026 ein operatives Ergebnis ohne Sondereffekte über den Markterwartungen und bestätigt den Ausblick für das Gesamtjahr 2026
Bayer Aktie: Zwei Katalysatoren, eine Woche
Die Bayer-Aktie rutscht am Montag um 2,21 Prozent auf 47,42 Euro ab. Auf 30-Tage-Sicht…
Der Beitrag Bayer Aktie: Zwei Katalysatoren, eine Woche erschien zuerst auf kapitalmarktexperten.de.
Quelle ka
Hess Midstream Partners Q2 Earnings Call Highlights
Key Points
- Interested in Hess Midstream Partners LP? Here are five stocks we like better.
- Strong second-quarter results: Net income rose to $174 million from approximately $158 million in the
Easterly Government Properties Q2 Earnings Call Highlights
Key Points
- Interested in Easterly Government Properties, Inc.? Here are five stocks we like better.
- Second-quarter performance improved: Revenue rose 10% year over year to $92.4 million, while
SK Hynix Aktie: Tim Cooks Lieferanten-Kommentar löst Ausverkauf aus
Ein Satz von Apple-Chef Tim Cook reicht, um den heißesten Chipwert Asiens ins Wanken…
Der Beitrag SK Hynix Aktie: Tim Cooks Lieferanten-Kommentar löst Ausverkauf aus erschien zuerst auf kapitalmarkt
5 Tech Stocks Holding Their Ground Through the AI Trade Pullback
Key Points
- Interested in Datadog, Inc.? Here are five stocks we like better.
- Despite a broader AI-driven selloff pushing the Nasdaq toward correction territory, Datadog, HPE, Dell, NetApp, and
Tyson Foods Q3 Earnings Call Highlights
Key Points
- Interested in Tyson Foods, Inc.? Here are five stocks we like better.
- Adjusted EPS rose 9% to $0.99 in fiscal Q3 2026, while sales were essentially flat at $13.9 billion as higher
CNH Industrial Q2 Earnings Call Highlights
Key Points
- Interested in CNH Industrial N.V.? Here are five stocks we like better.
- Second-quarter results were broadly in line with expectations: Revenue rose 2% to $4.8 billion and adjusted